New treatment option for advanced thymic carcinoma shows promise
Thymic epithelial tumors are a rare group of malignancies originating in the thymus gland, that includes thymoma and thymic carcinoma.
Wedbush cuts Arvinas to Neutral as VERITAC-2 shows monotherapy strategy limited
As previously reported, Wedbush analyst Robert Driscoll downgraded Arvinas (ARVN) to Neutral from Outperform with a price target of $12, down ...
Arvinas price target lowered to $20 from $82 at BMO Capital
BMO Capital analyst Etzer Darout lowered the firm’s price target on Arvinas (ARVN) to $20 from $82 and keeps an Outperform rating on the ...
Bloom is off the rose
Real-time stock price for Primerica Balanced Yield Fund (PCS117.CF), along with buy or sell indicators, analysis, charts, historical performance, news and more ...